4D Molecular Therapeutics Inc (FDMT)

NASDAQ
20.60
+0.37(+1.83%)
  • Volume:
    69,745
  • Day's Range:
    19.92 - 20.68
  • 52 wk Range:
    5.32 - 26.49

FDMT Overview

Prev. Close
20.23
Day's Range
19.92-20.68
Revenue
1.97M
Open
20.23
52 wk Range
5.32-26.49
EPS
-3.3
Volume
69,745
Market Cap
667.28M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
520,856
P/E Ratio
-6.12
Beta
1.85
1-Year Change
40.78%
Shares Outstanding
32,392,378
Next Earnings Date
Mar 27, 2023
What is your sentiment on 4D Molecular?
or
Vote to see community's results!

4D Molecular Therapeutics Inc News

4D Molecular Therapeutics Inc Analysis

4D Molecular Therapeutics Inc Company Profile

4D Molecular Therapeutics Inc Company Profile

4D Molecular Therapeutics, Inc. is a clinical-stage gene therapy company. The Company is focused on creating and developing targeted and evolved adeno-associated viruses (AAV) vectors. The Company’s product candidates are focused various areas, including ophthalmology, cardiology, and pulmonology. The Company's product candidates include 4D-125, 4D-150, 4D-110, 4D-310, and 4D-710. 4D-125 for the treatment of patients with X-Linked Retinitis Pigmentosa (XLRP) with retinitis pigmentosa GTPase regulator (RPGR) gene. 4D-150 is developed for the treatment of wet age-related macular degeneration (wet-AMD). 4D-110 is developed for the treatment of choroideremia. 4D-310 is developed for the systemic treatment of Fabry disease. The Company is developing 4D-710 for the treatment of a broad range of patients with cystic fibrosis independent of their cystic fibrosis transmembrane conductance regulator (CFTR).

Read More

Analyst Price Target

Average36.00 (+74.76% Upside)
High68.00
Low15.00
Price20.60
No. of Analysts6
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuyBuyBuy
Technical IndicatorsStrong BuyStrong BuyStrong BuySellStrong Buy
SummaryStrong BuyStrong BuyStrong BuyNeutralStrong Buy